Nano-X Imaging Ltd. (NNOX): History, Ownership, Mission, How It Works & Makes Money

Nano-X Imaging Ltd. (NNOX): History, Ownership, Mission, How It Works & Makes Money

IL | Healthcare | Medical - Devices | NASDAQ

Nano-X Imaging Ltd. (NNOX) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ever wondered how Nano-X Imaging Ltd. (NNOX), with its innovative medical imaging technology, is redefining the landscape of diagnostic imaging? As a pioneering company, NNOX combines a unique digital X-ray emitter with cloud-based software and AI algorithms, but how does this translate into real-world impact and financial performance? Keep reading to discover the history, ownership structure, mission, and revenue streams that drive this groundbreaking company, especially after reporting a GAAP net loss of $14.1 million for Q4 2024, compared to a $10.2 million loss in Q4 2023, and revenue increased to $3 million from $2.4 million in the same period last year.

Nano-X Imaging Ltd. (NNOX) History

Founding Timeline

Year established

Nano-X Imaging Ltd. was established in 2012.

Original location

The company was originally located in Israel.

Founding team members

The information about the specific founding team members is not readily available in the provided search results.

Initial capital/funding

Details regarding the initial capital and funding for Nano-X Imaging Ltd. are not available in the search results.

Evolution Milestones

Year Key Event Significance
2012 Company Founded Marked the beginning of Nano-X Imaging's journey to develop innovative medical imaging technology.
2019 Strategic Collaboration with SK Telecom This collaboration aimed to develop and deploy the 3D digital X-ray technology, enhancing Nano-X's market reach and technological capabilities.
2020 Initial Public Offering (IPO) Nano-X Imaging Ltd. went public, trading on the Nasdaq Stock Market under the ticker symbol NNOX. This IPO provided substantial funding to further develop and commercialize its technology.
2021 FDA Submission Nano-X submitted its multi-source Nanox.ARC for FDA 510(k) clearance.
2023 FDA Clearance Nano-X received FDA clearance for its single-source Nanox.ARC.

Transformative Moments

Nano-X Imaging Ltd. has experienced several transformative moments that have shaped its trajectory:

  • Strategic Partnerships: Collaborations with companies like SK Telecom have been crucial in expanding the company's technological capabilities and market presence.
  • Regulatory Milestones: Achieving FDA clearance for its single-source Nanox.ARC in 2023 was a pivotal moment, validating its technology and paving the way for commercial deployment.
  • Public Offering: The IPO in 2020 provided the necessary capital to advance research and development efforts.

To gain more insight into the company's goals and values, explore: Mission Statement, Vision, & Core Values of Nano-X Imaging Ltd. (NNOX).

Nano-X Imaging Ltd. (NNOX) Ownership Structure

Understanding Nano-X Imaging Ltd.'s ownership structure provides insights into who controls the company and whose interests are most closely aligned with its strategic direction. The ownership is distributed among various shareholders, including institutional investors, individual investors, and company insiders.

Nano-X Imaging Ltd.'s Current Status

Nano-X Imaging Ltd. is a publicly traded company, meaning its shares are available for purchase on the stock market. It is listed on the Nasdaq Stock Market under the ticker symbol NNOX.

Nano-X Imaging Ltd.'s Ownership Breakdown

The ownership of Nano-X Imaging Ltd. is distributed among various types of shareholders. As a publicly traded company, a significant portion of its shares are held by institutional investors. A detailed breakdown is presented in the table below.

Shareholder Type Ownership, % Notes
Institutional Investors 57.95% Includes investment firms, mutual funds, and hedge funds. Top institutional holders include ARK Investment Management LLC and BlackRock Fund Advisors.
Individual Investors and Insiders around 42% Comprises individual shareholders, company executives, and board members.
Other Less than 1% Includes any remaining shareholders not categorized above.

Nano-X Imaging Ltd.'s Leadership

The leadership team is responsible for the strategic direction and operational management of Nano-X Imaging Ltd. Key members of the leadership team as of April 2025 include:

  • Erez Meltzer: Chief Executive Officer
  • Itay Stern: Chief Financial Officer
  • Dr. Yuval Shani: Founder and Chief Technology Officer

For more insights into Nano-X Imaging Ltd.'s financial standing, you might find this resource helpful: Breaking Down Nano-X Imaging Ltd. (NNOX) Financial Health: Key Insights for Investors

Nano-X Imaging Ltd. (NNOX) Mission and Values

Nano-X Imaging Ltd., also known as Nanox, aims to increase early detection of medical conditions by making advanced medical imaging more accessible and affordable worldwide. The company focuses on combining its innovative digital X-ray source with cloud-based services to transform healthcare.

Nanox's Core Purpose

Official mission statement

Nanox's mission statement is: 'To increase early detection of medical conditions by making diagnostic imaging accessible and affordable worldwide.'

  • Nanox is dedicated to democratizing medical imaging, ensuring that more people have access to vital diagnostic tools, regardless of their location or economic status.
  • The company aims to deploy its Nanox.ARC system globally, offering a cost-effective alternative to traditional medical imaging technologies.
  • Nanox is focused on facilitating early and accurate diagnoses, which can lead to better treatment outcomes and improved overall health.

Vision statement

Nanox envisions a world where advanced medical imaging is readily available, enabling proactive healthcare and improving patient outcomes. This vision is supported by the development and deployment of the Nanox.ARC, designed to provide high-quality imaging at a reduced cost.

  • Nanox seeks to revolutionize the medical imaging landscape by replacing outdated analog technologies with its innovative digital solution.
  • The company aims to establish a global infrastructure of Nanox.ARC systems, ensuring widespread availability of advanced imaging services.
  • Nanox is committed to fostering partnerships with healthcare providers and organizations to expand the reach of its technology and improve patient care.

Company slogan/tagline

While specific slogans or taglines may evolve, Nanox's overarching message revolves around accessibility, affordability, and innovation in medical imaging. The company emphasizes its commitment to transforming healthcare through cutting-edge technology and a patient-centric approach.

  • Nanox focuses on communicating the benefits of its Nanox.ARC system, highlighting its potential to lower costs, improve diagnostic accuracy, and enhance patient access to care.
  • The company emphasizes its role in driving innovation in the medical imaging industry, challenging traditional paradigms and pushing the boundaries of what is possible.

More information can be found here: Mission Statement, Vision, & Core Values of Nano-X Imaging Ltd. (NNOX).

Nano-X Imaging Ltd. (NNOX) How It Works

Nano-X Imaging Ltd. (NNOX) is working to revolutionize medical imaging through its innovative digital X-ray source technology, aiming to make medical imaging more accessible and affordable globally.

Nano-X Imaging Ltd.'s Product/Service Portfolio

Product/Service Target Market Key Features
Nanox.ARC Hospitals, clinics, imaging centers, and mobile screening units. Digital X-ray source technology, lower imaging costs, potential for wider availability, multi-source array design.
Nanox.CLOUD Healthcare providers, teleradiology services, and payers. AI-powered diagnostic tools, cloud-based image analysis, facilitates remote diagnostics, supports efficient workflow.
Pay-per-Scan Business Model Healthcare facilities in developing and developed countries. No upfront costs for the Nanox.ARC system, revenue generation per scan performed, lowers financial barriers to entry, aligns incentives with usage.

Nano-X Imaging Ltd.'s Operational Framework

Nano-X operates with a focus on:

  • Technology Development: Continues to refine its digital X-ray source and Nanox.CLOUD platform, investing in R&D to enhance image quality and AI capabilities.
  • Manufacturing and Production: Establishes manufacturing capabilities to produce Nanox.ARC systems, working with strategic partners to scale production.
  • Regulatory Approvals: Pursues regulatory clearances (e.g., FDA approval) in key markets to enable commercial deployment.
  • Partnerships: Collaborates with healthcare providers, technology companies, and distributors to expand market reach.
  • Commercialization: Implements a pay-per-scan business model, targeting both developed and developing countries to increase access to medical imaging.

Nano-X Imaging Ltd.'s Strategic Advantages

Nano-X possesses several strategic advantages:

  • Innovative Technology: The digital X-ray source has the potential to significantly reduce the cost and complexity of medical imaging systems.
  • Pay-per-Scan Model: This business model reduces upfront costs for healthcare providers, making advanced imaging more accessible, particularly in underserved areas.
  • AI-Powered Cloud Platform: Nanox.CLOUD enhances diagnostic capabilities and streamlines workflows, adding value for healthcare professionals.
  • Scalability: The design of Nanox.ARC and Nanox.CLOUD allows for scalability, enabling the company to expand its reach and impact.

To gain more insights into the company's foundational principles, explore the Mission Statement, Vision, & Core Values of Nano-X Imaging Ltd. (NNOX).

Nano-X Imaging Ltd. (NNOX) How It Makes Money

Nano-X Imaging Ltd. primarily aims to generate revenue through the deployment and operation of its innovative medical imaging system, the Nanox.ARC. The company intends to profit from a pay-per-scan business model, alongside other potential revenue streams such as service fees and software solutions.

[Company's] Revenue Breakdown

As the Nanox.ARC system is still in its early stages of commercialization, a detailed breakdown of revenue streams as a percentage of the total is not yet fully established for the 2024 fiscal year. However, based on the company's business model, we can project potential revenue streams and their anticipated growth.

Revenue Stream % of Total Growth Trend
Pay-Per-Scan Services Anticipated to be the primary revenue source upon full deployment Increasing
Service and Maintenance Fees Expected to contribute a smaller percentage initially, growing as the installed base expands Increasing
Software Solutions and AI Potential for future revenue, dependent on development and market adoption Increasing

[Company's] Business Economics

The business economics of Nano-X Imaging are centered around making medical imaging more accessible and affordable. Key aspects include:

  • Pay-Per-Scan Model: This is designed to lower the initial cost barrier for healthcare providers, allowing them to offer advanced imaging services without significant capital expenditure. The cost per scan needs to be competitive compared to traditional modalities while providing sufficient margin for Nano-X.
  • Manufacturing and Production Costs: The company focuses on efficient manufacturing processes to keep the production costs of the Nanox.ARC system low.
  • Global Expansion: Economic viability depends on successful deployment in diverse markets, including regions with limited access to medical imaging.

[Company's] Financial Performance

As of the fiscal year 2024, key aspects of financial performance include:

  • Revenue Generation: While specific revenue figures are still evolving, the focus remains on initiating commercial operations and securing initial contracts.
  • R&D Investments: Significant investments in research and development continue to be a priority as the company refines its technology and expands its applications.
  • Strategic Partnerships: Forming partnerships with healthcare providers and distributors is crucial for market penetration and revenue scaling.

To gain more insights into the investors and stakeholders involved with Nano-X Imaging Ltd., check out this profile: Exploring Nano-X Imaging Ltd. (NNOX) Investor Profile: Who’s Buying and Why?

Nano-X Imaging Ltd. (NNOX) Market Position & Future Outlook

Nano-X Imaging Ltd. is strategically positioned to capitalize on innovative medical imaging technologies, holding promise for significant advancements in early disease detection and healthcare accessibility. While the company navigates a competitive landscape, its focus on affordability and widespread deployment presents both opportunities and challenges for future growth.

Competitive Landscape

Company Market Share, % Key Advantage
Nano-X Imaging Ltd. Estimated at less than 1% as of 2024, reflecting its early stage in the market. Focus on affordable, portable imaging solutions aimed at expanding access to medical imaging.
General Electric Healthcare Approximately 25-30% in 2024. Extensive product portfolio, established global presence, and strong brand reputation.
Siemens Healthineers Around 20-25% in 2024. Advanced technology, comprehensive service offerings, and a large installed base.

Opportunities & Challenges

Opportunities Risks
Expanding access to underserved markets with affordable imaging solutions. Regulatory hurdles and delays in obtaining necessary approvals for its technology.
Strategic partnerships with healthcare providers and distributors to broaden market reach. Competition from established players with greater resources and market presence.
Development of new applications for its technology, such as early disease detection and remote diagnostics. Technological challenges and the need for continuous innovation to stay ahead of the competition.

Industry Position

Nano-X Imaging operates within the medical imaging equipment industry, a sector characterized by rapid technological advancements and increasing demand for diagnostic imaging. The company's industry standing can be further understood through the following points:

  • Innovative Technology: Nano-X's technology represents a novel approach to X-ray imaging, potentially offering lower costs and greater accessibility compared to traditional systems.
  • Market Disruption Potential: By targeting underserved markets and offering affordable solutions, Nano-X has the potential to disrupt the traditional medical imaging market.
  • Regulatory Scrutiny: As a relatively new player with innovative technology, Nano-X faces significant regulatory scrutiny and must demonstrate the safety and efficacy of its products to gain market acceptance.

To delve deeper into the company's foundational principles, explore Mission Statement, Vision, & Core Values of Nano-X Imaging Ltd. (NNOX).

DCF model

Nano-X Imaging Ltd. (NNOX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.